Innovation For Cancer and Autoimmune Disease Healthcare

With Precision Engineering and Machine Learning

Precision Engineering for Biologics

Transforming cancer healthcare requires more targeted, more effective, and less toxic therapies. Biologics like ADCs and monoclonal antibodies are emerging therapeutics. Development of precision bioengineering provides the foundation for future biological therapeutics development

Pipeline

Cancer

Autoimmune

Science and technology

Advanced analytics and machine learning

Precision bioengineering.

Leadership

Experienced and dedicated scientists and entrepreneurs

Precision Bio-targeting

Biologics with precision binding .

A Legacy of Excellence: Our Mission and Goals

Next generation biologics for cancer and autoimmune disease.

Introducing the Extraordinary Individuals Who Comprise Our Team of Experts

Mathew Patt

Founder – Patt Technologies

Melinda C

CTO – Patt Technologies

Alexander Lyn

CFO – Patt Technologies

Author

Checkout Our Recent News & Insights

Clinical trials and breakthrough discoveries.